Sanofi-Aventis Launches Bid for Genzyme

Oct. 4, 2010
Genzyme management says bid is undervalued.

French pharmaceutical giant Sanofi-Aventis said Oct. 4 it had launched a hostile $18.5 billion bid for U.S. biotechnology company Genzyme, a proposal Genzyme management spurned in late August.

"Genzyme's refusal to take part in constructive discussions has led Sanofi-Aventis to put forward its offer directly to shareholders," Sanofi said in a statement.

The company said its bid, at $69 per share, would remain open until Dec. 10.

At $69 the offer amounts to a 38% premium on Genzyme's closing share price, $49.86, on the New York Stock Exchange on July 1, the date on which reports of Sanofi's intentions first surfaced.
Genzyme shares closed at $70.90 on Oct.1.

Genzyme management has until now insisted that Sanofi's proposal greatly undervalues the U.S. group.

Genzyme chief executive Henri Termeer has said an offer pitched at $80 a share would more accurately reflect the value of the company.

But the head of Sanofi-Aventis, Christopher Viehbacher, insisted Oct. 4 that "our offer reflects both the growth potential of the company and the operational challenges that are confronting it."

Copyright Agence France-Presse, 2010

Popular Sponsored Recommendations

How to Build Zero-Cost On-Site Solar and Storage Projects

Nov. 25, 2023
The Inflation Reduction Act offers tax credits, incentives, and financing that enable no-cost projects. In Enel’s eBook, discover the critical role that incentives play in your...

Why DataOps may be the key to unlocking the full potential of digital transformation

Nov. 3, 2023
Read the 2023 market survey conducted by IndustryWeek

Powering Up Productivity: The Transformative Power of AP Automation in Manufacturing

Oct. 25, 2023
Discover how AP Automation is revolutionizing the manufacturing industry, driving efficiency, cost savings, and security. In today's world, automation is the key to staying competitive...

How Manufacturers Can Optimize Operations with Weather Intelligence

Nov. 2, 2023
The bad news? Severe weather has emerged as one of the biggest threats to continuity and safety in manufacturing. The good news? The intelligence solutions that build weather ...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!